CA Patent

CA2719876A1 — Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists

Assigned to Individual · Expires 2009-10-08 · 17y expired

What this patent protects

The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of .beta.3-adrenoceptor.

USPTO Abstract

The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of .beta.3-adrenoceptor.

Drugs covered by this patent

Patent Metadata

Patent number
CA2719876A1
Jurisdiction
CA
Classification
—
Expires
2009-10-08
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.